PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Cell and Gene Therapy

Upcoming Events

SLAS Europe – 7th April 2025
PEGS Boston – 17/02/2025
Biotechnology Show 2025: 20th January 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025

The Era of Pharma and Biotech Outsourcing is Here to Stay

Over the past ten years, more and more pharma and biotech companies have turned to CROs, CMOs and CDMOs to assist in the preformulation, development and manufacturing of their latest innovations. Outsourcing is now a multi-billion dollar industry. Most spending is focused on early development, with around two-thirds of annual spending being outsourced. This report, commissioned by Biopharma Group, discusses why so many pharma and biotech companies have transitioned from doing their R&D in-house to outsourcing it.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2018/12/The-era-of-pharma-and-biotech.pdf” width=”100%” height=”900px” style=”border:0;”]

Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
Tosoh – 29.04.25
Eppendorf – 18.03.2025
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025